放疗治疗恶性雀斑样痣与恶性雀斑样黑素瘤的系统综述
该系统综述检索MEDLINE和Embase(2019年9月),纳入14项患者系列研究、共1243个病灶(1075例LM和168例LMM),未发现前瞻性试验。局部复发率0–31%,多数报告与手术系列相当;美容结果多为「好」至「极好」。低级别证据提示放疗可能是LM和LMM安全有效的治疗,需RADICAL等前瞻性试验确认。
要点
- 14项回顾性系列共1243个病灶(LM 1075、LMM 168),无前瞻性试验。
- 局部复发率0–31%,多数报告与手术系列相当。
- 浅表放疗5–23次、总量35–57 Gy;Grenz线3–13次、42–160 Gy、单次最高20 Gy。
核心结论
- 现有低级别证据提示放疗可能是LM和LMM安全有效的治疗。
- 需RADICAL等3期试验确认并与手术及其他非手术治疗比较。
研究设计与样本
- 系统综述,检索MEDLINE和Embase数据库(2019年9月)。
- 纳入14项使用放疗治疗LM或LMM的患者系列研究,未发现前瞻性试验。
主要发现
- 14项研究共报告1243个病灶,其中LM 1075个、LMM 168个。
- 局部复发率范围为0至31%。
- 多数放疗报告的美容结果被评价为「好」至「极好」。
关键数值与推荐
- 浅表放疗处方为5–23次,总剂量35–57 Gy。
- Grenz线治疗处方为42–160 Gy,分3–13次,单次剂量最高20 Gy。
临床怎么用
- 对因年龄、合并症或患者意愿无法手术的LM或LMM,可考虑Grenz线或浅表X线放疗作为非侵入性替代。
局限性
- 仅纳入回顾性患者系列,无前瞻性试验,证据级别低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lentigo maligna (LM) is the most common subtype of in situ melanoma und occurs frequently in the sun-exposed head and neck region in elderly patients. The therapeutic "gold standard" is surgical excision, as there is the risk of progression to invasive (lentigo maligna) melanoma (LMM). However, surgery is not feasible in certain patients due to age, comorbidities or patient preference. Radiotherapy using Grenz rays or superficial X-rays has been established as non-invasive alternative for the treatment of LM and LMM. We performed a systematic literature search of MEDLINE and Embase databases in September 2019 and identified 14 patient series using radiotherapy for LM or LMM. No prospective trials were found. The 14 studies reported a total of 1243 lesions (1075 LM and 168 LMM) treated with radiotherapy. Local recurrence rates ranged from 0 to 31% and were comparable to surgical series in most of the reports on radiotherapy. Superficial radiotherapy was prescribed in 5-23 fractions with a total dose of 35-57 Gy. Grenz ray therapy was prescribed in 42-160 Gy in 3-13 fractions with single doses up to 20 Gy. Cosmetic results were reported as "good" to "excellent" for the majority of patients.In conclusion, the available low-level evidence suggests that radiotherapy may be a safe and effective treatment for LM and LMM. Data from prospective trials such as the phase 3 RADICAL trial are needed to confirm these promising findings and to compare radiotherapy to other non-surgical therapies and to surgery.
引用
- Hendrickx A, Cozzio A, Plasswilm L, et al. Radiotherapy for lentigo maligna and lentigo maligna melanoma - a systematic review. Radiat Oncol. 2020. PMID: 32664998. doi:10.1186/s13014-020-01615-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。